Back
ProQR Therapeutics NV Quote, Financials, Valuation and Earnings
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
PRQR
ProQR Therapeutics NV
Last Price:
1.74
Seasonality Move:
-2.94%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.ProQR Therapeutics NV Price Quote
$1.74
-0.05 (-2.79%)
(Updated: September 20, 2024 at 2:45 PM ET)
ProQR Therapeutics NV Key Stats
Sell
27
ProQR Therapeutics NV (PRQR)
is a Sell
Day range:
$1.76 - $1.82
52-week range:
$1.11 - $3.29
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.75
P/B ratio:
4.15%
Volume:
69.3K
Avg. volume:
125.9K
1-year change:
16.23%
Market cap:
$146.2M
Revenue:
$7.1M
EPS:
$-0.28
How Much Does ProQR Therapeutics NV Make?
-
How Much Are ProQR Therapeutics NV's Sales Annually?
PRQR Revenues are $7.1M -
How Much Profit Does ProQR Therapeutics NV's Make A Year?
PRQR net income is -$30.4M
Is ProQR Therapeutics NV Growing As A Company?
-
What Is ProQR Therapeutics NV's Growth Rate Quarterly?
Quarterly YoY revenue growth is 4.17% -
What Is ProQR Therapeutics NV's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ProQR Therapeutics NV Stock Price Performance
-
Did ProQR Therapeutics NV Stock Go Up Last Month?
ProQR Therapeutics NV share price went down by -13.94% last month -
Did PRQR's Share Price Rise Over The Last Year?
PRQR share price rose by 16.23% over the past 1 year
What Is ProQR Therapeutics NV 52-Week High & Low?
-
What Is ProQR Therapeutics NV’s 52-Week High Share Price?
ProQR Therapeutics NV has traded as high as $3.29 over the past 52 weeks -
What Is ProQR Therapeutics NV’s 52-Week Low Share Price?
ProQR Therapeutics NV has traded as low as $1.11 over the past 52 weeks
ProQR Therapeutics NV Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ProQR Therapeutics NV?
-
How Much Debt Does ProQR Therapeutics NV Have?
Total long term debt quarterly is $4.8M -
How Much Cash Does ProQR Therapeutics NV Have?
Cash and short term investments quarterly total is $103.1M -
What Is ProQR Therapeutics NV’s Book Value Per Share?
Book value per share is 0.43
Is ProQR Therapeutics NV Cash Flow Positive?
-
What Is PRQR Cash Flow From Operations?
Cash flow from operations (TTM) is -$37.2M -
What Is ProQR Therapeutics NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2.2M -
What Is ProQR Therapeutics NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$14.3M
ProQR Therapeutics NV Return On Invested Capital
-
Is Management Doing A Good Job?
PRQR return on invested capital is -46.6% -
What Is ProQR Therapeutics NV Return On Assets?
ROA measures how assets are converting to revenues and is -16.12% -
What Is PRQR Return On Equity?
ROE is a measure of profitability and is -52.19%
ProQR Therapeutics NV Earnings Date & Stock Price
-
What Is ProQR Therapeutics NV's Stock Price Today?
A single share of PRQR can be purchased today for 1.79 -
What Is ProQR Therapeutics NV’s Stock Symbol?
ProQR Therapeutics NV trades on the nasdaq under the ticker symbol: PRQR -
When Is ProQR Therapeutics NV’s Next Earnings Date?
The next quarterly earnings date for ProQR Therapeutics NV is scheduled on November 7, 2024 -
When Is PRQR's next ex-dividend date?
ProQR Therapeutics NV's next ex-dividend date is September 20, 2024 -
How To Buy ProQR Therapeutics NV Stock?
You can buy ProQR Therapeutics NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ProQR Therapeutics NV Competitors
-
Who Are ProQR Therapeutics NV's Competitors?
Below is a list of companies who compete with ProQR Therapeutics NV or are related in some way:
ProQR Therapeutics NV Dividend Yield
-
What Is PRQR Dividend Yield?
ProQR Therapeutics NV’s dividend yield currently is 0% -
What Is ProQR Therapeutics NV’s Payout Ratio?
ProQR Therapeutics NV’s payout ratio is 0% -
When Did ProQR Therapeutics NV Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is ProQR Therapeutics NV’s Dividend Per Share?
ProQR Therapeutics NV pays a dividend of $0.00 per share
ProQR Therapeutics NV Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 77.28% |
| Revenue: | 416.67% | -36.83% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 4.13 |
| Upside from Last Price: | 130.73% |